Lawrence Conway - CMD President
Lawrence Conway is Portfolio Manager at CMD
Conway joined Cantel in September 2013 as Vice President, Business Systems & Procurement. Since that time, he has made significant contributions to the Company including successfully building a single, global IT function, and leading the implementation of the Company global ERP platform. In addition, Mr. Conway was instrumental in the creation and management of Cantel strategic procurement organization and the development and execution of sourcing strategies across the Company. Prior to joining Cantel, Mr. Conway worked at ConvaTec for 11 years, where he was most recently Vice President and General Manager, Ostomy Care. He also played an instrumental role in the divestiture of the company from BristolMyers Squibb. Prior to that, Mr. Conway worked as a Management Consultant at several firms including McKinsey & Company and Andersen Consulting where he held various roles with increasing responsibility.
Mr. Lawrence Conway is Senior Vice President Business Systems and Integration of the Company
| Age | 54 |
| Tenure | 6 years |
| Phone | 973 890-7270 |
| Web | www.cantelmedical.com |
CMD Management Efficiency
The company has Return on Asset of 4.24 % which means that on every $100 spent on assets, it made $4.24 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 6.19 %, implying that it generated $6.19 on every 100 dollars invested. CMD's management efficiency ratios could be used to measure how well CMD manages its routine affairs as well as how well it operates its assets and liabilities.The company has 1.01 B in debt with debt to equity (D/E) ratio of 1.28, which is OK given its current industry classification. CMD has a current ratio of 2.67, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist CMD until it has trouble settling it off, either with new capital or with free cash flow. So, CMD's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CMD sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CMD to invest in growth at high rates of return. When we think about CMD's use of debt, we should always consider it together with cash and equity.
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. Cantel Medical is listed under Medical Instruments Supplies in the United States and is traded on New York Stock Exchange exchange. CMD [CMD] is traded in USA and was established November 24, 2008. Management Performance
| Return On Equity | 6.19 | |||
| Return On Asset | 4.24 |
CMD Money Managers
| David Watkins, Non-Executive Independent Chairman of the Board | ||
| Bernard Kahlert, Vice President - Corporate Development, Director | ||
| Stephen Wetherup, Vice President of Exploration | ||
| Bruce Slovin, Independent Director | ||
| Jean Casnerhas, Chief Human Resource Officer, Senior Vice President | ||
| Seth Yellin, Executive Vice President - Strategy and Corporate Development | ||
| Jeffrey Mann, Senior Vice President General Counsel, Secretary | ||
| Steven Anaya, Senior Vice President Chief Accounting Officer | ||
| Peter Clifford, President, Chief Operating Officer | ||
| Alan Batkin, Presiding Independent Director | ||
| Robert Cameron, President CEO | ||
| Eric Nodiff, Executive Vice President General Counsel, Secretary | ||
| Shaun Blakeman, Chief Financial Officer, Senior Vice President | ||
| Dottie DonnellyBrienza, Chief Human Resource Officer, Senior Vice President | ||
| Joseph Cohen, Independent Director | ||
| Lawrence Conway, Senior Vice President - Business Systems and Procurement | ||
| ERichard Moyer, IR Contact Officer | ||
| Peter Pronovost, Independent Director | ||
| Charles Diker, Chairman of the Board | ||
| Michael Drexel, Senior Vice President, Chief Technology Officer | ||
| Eric Norton, Director | ||
| George Fotiades, Chief Executive Officer, Director | ||
| Karen Prange, Independent Director | ||
| Mark Diker, Director | ||
| Ann Berman, Independent Director | ||
| Laura Forese, Independent Director | ||
| Jean Casner, Chief Human Resource Officer, Senior Vice President | ||
| Cathy Divito, Manager - Corporate Communications | ||
| Patricia Fong, CFO | ||
| Brian Capone, Senior Vice President - Chief Accounting Officer, Corporate Controller | ||
| Anthony Evnin, Independent Director | ||
| Ronnie Myers, Independent Director | ||
| Bill Haydon, Senior Vice President and General Manager - Medical | ||
| Jorgen Hansen, President CEO, Director |
CMD Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is CMD a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 6.19 | |||
| Return On Asset | 4.24 | |||
| Profit Margin | 4.40 % | |||
| Operating Margin | 19.08 % | |||
| Current Valuation | 4.15 B | |||
| Shares Outstanding | 42.27 M | |||
| Shares Owned By Insiders | 21.04 % | |||
| Shares Owned By Institutions | 89.83 % | |||
| Number Of Shares Shorted | 2.49 M | |||
| Price To Earning | 73.80 X |
Pair Trading with CMD
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CMD will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to NiSource could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NiSource when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NiSource - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NiSource to buy it.
The correlation of NiSource is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NiSource moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NiSource moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NiSource can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Tools for CMD Etf
When running CMD's price analysis, check to measure CMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CMD is operating at the current time. Most of CMD's value examination focuses on studying past and present price action to predict the probability of CMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CMD's price. Additionally, you may evaluate how the addition of CMD to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |